1. Home
  2. PFN vs FTRE Comparison

PFN vs FTRE Comparison

Compare PFN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Income Strategy Fund II

PFN

PIMCO Income Strategy Fund II

HOLD

Current Price

$7.07

Market Cap

699.5M

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.04

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFN
FTRE
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.5M
829.3M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
PFN
FTRE
Price
$7.07
$9.04
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$14.17
AVG Volume (30 Days)
681.2K
1.1M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$6.53
$3.97
52 Week High
$7.65
$18.67

Technical Indicators

Market Signals
Indicator
PFN
FTRE
Relative Strength Index (RSI) 56.10 40.56
Support Level $6.53 $8.85
Resistance Level $7.56 $11.22
Average True Range (ATR) 0.11 0.66
MACD 0.06 0.12
Stochastic Oscillator 95.54 27.72

Price Performance

Historical Comparison
PFN
FTRE

About PFN PIMCO Income Strategy Fund II

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: